2
|
Marttila S, Viiri LE, Mishra PP, Kühnel B, Matias-Garcia PR, Lyytikäinen LP, Ceder T, Mononen N, Rathmann W, Winkelmann J, Peters A, Kähönen M, Hutri-Kähönen N, Juonala M, Aalto-Setälä K, Raitakari O, Lehtimäki T, Waldenberger M, Raitoharju E. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs. Clin Epigenetics 2021; 13:143. [PMID: 34294131 PMCID: PMC8296652 DOI: 10.1186/s13148-021-01132-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 07/13/2021] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Non-coding RNA 886 (nc886) is coded from a maternally inherited metastable epiallele. We set out to investigate the determinants and dynamics of the methylation pattern at the nc886 epiallele and how this methylation status associates with nc886 RNA expression. Furthermore, we investigated the associations between the nc886 methylation status or the levels of nc886 RNAs and metabolic traits in the YFS and KORA cohorts. The association between nc886 epiallele methylation and RNA expression was also validated in induced pluripotent stem cell (iPSC) lines. RESULTS We confirm that the methylation status of the nc886 epiallele is mostly binomial, with individuals displaying either a non- or hemi-methylated status, but we also describe intermediately and close to fully methylated individuals. We show that an individual's methylation status is associated with the mother's age and socioeconomic status, but not with the individual's own genetics. Once established, the methylation status of the nc886 epiallele remains stable for at least 25 years. This methylation status is strongly associated with the levels of nc886 non-coding RNAs in serum, blood, and iPSC lines. In addition, nc886 methylation status associates with glucose and insulin levels during adolescence but not with the indicators of glucose metabolism or the incidence of type 2 diabetes in adulthood. However, the nc886-3p RNA levels also associate with glucose metabolism in adulthood. CONCLUSIONS These results indicate that nc886 metastable epiallele methylation is tuned by the periconceptional conditions and it associates with glucose metabolism through the expression of the ncRNAs coded in the epiallele region.
Collapse
Grants
- 755320 Horizon 2020 (Taxinomisis)
- WA 4081/1-1 German Research Foundation
- BB/S020845/1 Biotechnology and Biological Sciences Research Council
- 134309, 126925, 121584, 124282, 129378, 117787, 41071 Academy of Finland
- 286284 and 322098 Academy of Finland
- 01EA1902A Joint Programming Initiative A healthy diet for a healthy life (DIMENSION)
- 848146 Horizon 2020 (To_Aition)
- 9X047, 9S054, and 9AB059 Tampere University Hospital Medical Funds
- 742927 European Research Council (MULTIEPIGEN)
- 285902, 330809 and 338395 academy of finland
- X51001 Tampere University Hospital Medical Funds
- the Social Insurance Institution of Finland
- Kuopio, Tampere, and Turku University Hospital Medical Funds
- Juho Vainion Säätiö
- Paavo Nurmen Säätiö
- Sydäntutkimussäätiö
- Suomen Kulttuurirahasto
- Tampereen Tuberkuloosisäätiö
- Emil Aaltosen Säätiö
- Yrjö Jahnssonin Säätiö
- Signe ja Ane Gyllenbergin Säätiö
- Diabetesliitto
- the Tampere University Hospital Supporting Foundation
- the Finnish Society of Clinical Chemistry
- Foundation of Clinical Chemistry
- Laboratoriolääketieteen edistämissäätiö sr.
- Orionin Tutkimussäätiö
- the Paulo Foundation
- Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München
- German Federal Ministry of Education and Research
- State of Bavaria
Collapse
Affiliation(s)
- Saara Marttila
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland.
- Gerontology Research Center, Tampere University, Tampere, Finland.
| | - Leena E Viiri
- Heart Group, Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Pashupati P Mishra
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Brigitte Kühnel
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany
| | - Pamela R Matias-Garcia
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Tiina Ceder
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Nina Mononen
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Wolfgang Rathmann
- German Center for Diabetes Research (DZD), Munich, Neuherberg, Germany
- Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research At Heinrich Heine University, Düsseldorf, Germany
- Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Juliane Winkelmann
- Institute of Neurogenomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Department of Neurogenetics and Institute of Human Genetics, Technical University of Munich, Munich, Germany
| | - Annette Peters
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany
- German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
| | - Mika Kähönen
- Department of Clinical Physiology, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
| | - Nina Hutri-Kähönen
- Tampere Centre for Skills Training and Simulation, Tampere University, Tampere, Finland
| | - Markus Juonala
- Division of Medicine, Department of Medicine, Turku University Hospital, University of Turku, Turku, Finland
| | - Katriina Aalto-Setälä
- Heart Group, Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
- Heart Hospital, Tampere University Hospital, Tampere University, Tampere, Finland
| | - Olli Raitakari
- Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
- Department of Clinical Physiology and Nuclear Medicine, University of Turku, Turku University Hospital, Turku, Finland
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Melanie Waldenberger
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany
- German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
| | - Emma Raitoharju
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland.
- Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.
| |
Collapse
|
3
|
Marttila S, Viiri LE, Mishra PP, Kühnel B, Matias-Garcia PR, Lyytikäinen LP, Ceder T, Mononen N, Rathmann W, Winkelmann J, Peters A, Kähönen M, Hutri-Kähönen N, Juonala M, Aalto-Setälä K, Raitakari O, Lehtimäki T, Waldenberger M, Raitoharju E. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs. Clin Epigenetics 2021. [PMID: 34294131 DOI: 10.1186/s13148‐021‐01132‐3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Non-coding RNA 886 (nc886) is coded from a maternally inherited metastable epiallele. We set out to investigate the determinants and dynamics of the methylation pattern at the nc886 epiallele and how this methylation status associates with nc886 RNA expression. Furthermore, we investigated the associations between the nc886 methylation status or the levels of nc886 RNAs and metabolic traits in the YFS and KORA cohorts. The association between nc886 epiallele methylation and RNA expression was also validated in induced pluripotent stem cell (iPSC) lines. RESULTS We confirm that the methylation status of the nc886 epiallele is mostly binomial, with individuals displaying either a non- or hemi-methylated status, but we also describe intermediately and close to fully methylated individuals. We show that an individual's methylation status is associated with the mother's age and socioeconomic status, but not with the individual's own genetics. Once established, the methylation status of the nc886 epiallele remains stable for at least 25 years. This methylation status is strongly associated with the levels of nc886 non-coding RNAs in serum, blood, and iPSC lines. In addition, nc886 methylation status associates with glucose and insulin levels during adolescence but not with the indicators of glucose metabolism or the incidence of type 2 diabetes in adulthood. However, the nc886-3p RNA levels also associate with glucose metabolism in adulthood. CONCLUSIONS These results indicate that nc886 metastable epiallele methylation is tuned by the periconceptional conditions and it associates with glucose metabolism through the expression of the ncRNAs coded in the epiallele region.
Collapse
Affiliation(s)
- Saara Marttila
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland. .,Gerontology Research Center, Tampere University, Tampere, Finland.
| | - Leena E Viiri
- Heart Group, Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
| | - Pashupati P Mishra
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Brigitte Kühnel
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany.,Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany
| | - Pamela R Matias-Garcia
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany.,Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Tiina Ceder
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Nina Mononen
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Wolfgang Rathmann
- German Center for Diabetes Research (DZD), Munich, Neuherberg, Germany.,Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research At Heinrich Heine University, Düsseldorf, Germany.,Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Juliane Winkelmann
- Institute of Neurogenomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.,Department of Neurogenetics and Institute of Human Genetics, Technical University of Munich, Munich, Germany
| | - Annette Peters
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany.,German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
| | - Mika Kähönen
- Department of Clinical Physiology, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
| | - Nina Hutri-Kähönen
- Tampere Centre for Skills Training and Simulation, Tampere University, Tampere, Finland
| | - Markus Juonala
- Division of Medicine, Department of Medicine, Turku University Hospital, University of Turku, Turku, Finland
| | - Katriina Aalto-Setälä
- Heart Group, Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.,Heart Hospital, Tampere University Hospital, Tampere University, Tampere, Finland
| | - Olli Raitakari
- Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.,Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.,Department of Clinical Physiology and Nuclear Medicine, University of Turku, Turku University Hospital, Turku, Finland
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland
| | - Melanie Waldenberger
- Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Bavaria, Germany.,Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany.,German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
| | - Emma Raitoharju
- Department of Clinical Chemistry, Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Pirkanmaa Hospital District and Fimlab Laboratories, Tampere, Finland. .,Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.
| |
Collapse
|
5
|
Puolakka E, Pahkala K, Laitinen TT, Magnussen CG, Hutri-Kähönen N, Kähönen M, Lehtimäki T, Tossavainen P, Jokinen E, Sabin MA, Laitinen T, Elovainio M, Pulkki-Råback L, Viikari JSA, Raitakari OT, Juonala M. Childhood Socioeconomic Status and Arterial Stiffness in Adulthood: The Cardiovascular Risk in Young Finns Study. Hypertension 2017; 70:729-735. [PMID: 28808067 DOI: 10.1161/hypertensionaha.117.09718] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2017] [Revised: 05/28/2017] [Accepted: 07/24/2017] [Indexed: 12/27/2022]
Abstract
Increasing evidence supports the importance of socioeconomic factors in the development of atherosclerotic cardiovascular disease. However, the association of childhood socioeconomic status (SES) with arterial stiffness in adulthood has not been reported. Our aim was to determine whether higher childhood family-level SES is associated with lower arterial stiffness in adulthood. The analyses were performed using data gathered within the longitudinal Young Finns Study. The sample comprised 2566 participants who had data concerning family SES at ages 3 to 18 years in 1980 and arterial pulse wave velocity and carotid artery distensibility measured 21 or 27 years later in adulthood. Higher family SES in childhood was associated with lower arterial stiffness in adulthood; carotid artery distensibility being higher (β value±SE, 0.029±0.0089%/10 mm Hg; P=0.001) and pulse wave velocity lower (β value±SE, -0.062±0.022 m/s; P=0.006) among those with higher family SES in a multivariable analysis adjusted with age, sex, and conventional childhood cardiometabolic risk factors. The association remained significant after further adjustment for participant's SES in adulthood (β value±SE, 0.026±0.010%/10 mm Hg; P=0.01 for carotid artery distensibility and β value±SE, -0.048±0.023 m/s; P=0.04 for pulse wave velocity) but attenuated after adjustment for adulthood cardiometabolic risk factors (β value±SE, 0.015±0.008%/10 mm Hg; P=0.08 for carotid artery distensibility and β value±SE, -0.019±0.02 m/s; P=0.38 for pulse wave velocity). In conclusion, we observed an association between higher family SES in childhood and lower arterial stiffness in adulthood. Our findings suggest that special attention could be paid to children from low SES families to prevent cardiometabolic diseases primordially.
Collapse
Affiliation(s)
- Elina Puolakka
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.).
| | - Katja Pahkala
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Tomi T Laitinen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Costan G Magnussen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Nina Hutri-Kähönen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Mika Kähönen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Terho Lehtimäki
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Päivi Tossavainen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Eero Jokinen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Matthew A Sabin
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Tomi Laitinen
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Marko Elovainio
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Laura Pulkki-Råback
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Jorma S A Viikari
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Olli T Raitakari
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| | - Markus Juonala
- From the Research Centre of Applied and Preventive Cardiovascular Medicine (E.P., K.P., T.T.L., C.G.M., O.T.R., M.J.), Department of Physical Activity and Health, Sports and Exercise Medicine Unit, Paavo Nurmi Centre (K.P., T.T.L.), and Department of Medicine (J.S.A.V., M.J.), University of Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (C.G.M.); Department of Pediatrics (N.H.-K.) and Department of Clinical Physiology (M.K.), Tampere University Hospital and University of Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Finland (T. Lehtimäki); Department of Pediatrics, PEDEGO Research Unit and Medical Research Center, Oulu University Hospital and University of Oulu, Finland (P.T.); Department of Pediatric Cardiology, Hospital for Children and Adolescents (E.J.), Unit of Personality, Work, and Health, Institute of Behavioural Sciences (M.E., L.P.-R.), and Helsinki Collegium for Advanced Studies, University of Helsinki, Finland (L.P.-R.); Murdoch Childrens Research Institute, Royal Children's Hospital, Australia (M.A.S.); Department of Pediatrics, University of Melbourne, Victoria, Australia (M.A.S.); Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland (T. Laitinen); Division of Medicine, Turku University Hospital, Finland (J.S.A.V., M.J.); and Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Finland (O.T.R.)
| |
Collapse
|